Primavera Capital Group

Primavera Capital Group is a china-based investment firm, focusing on private equity and special situations opportunities.

Business Model:

Revenue: $185.4M

Employees: 51-200

Rankings

Detailed Primavera Capital Group Information

Geographic Data

Primavera Capital Group headquarters map

Address: No.1 Jian Guo Men Wai Avenue

City: Beijing

State: beijing municipality

Zip: 100004

Country: CN

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$5B

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Primavera Capital Group is a China-based global investment firm. With offices located in Beijing and Hong Kong, Primavera manages both RMB and USD funds for leading institutions, corporations, and families in China and around the world. Primavera Capital Group was founded by Dr. Fred Hu, a renowned economist and successful investor, and a former partner and Chairman of Greater China at Goldman Sachs Group. The firm currently has 30+ investment professionals with an outstanding track record. The team combines global capital market experience, deep industry knowledge, and a unique network of relationships with policy-makers and regulators as well as leading CEOs and entrepreneurs in the region and globally. Primavera Capital Group puts great emphasis on rigorous fundamental research. The firm undertakes sophisticated analysis on economies, industries and companies to generate investment ideas, identify attractive opportunities, and guide its investment decisions. Primavera Capital Group employs a flexible investment strategy of growth capital, buy-out and control, and special situations - restructuring, distressed, and turn-arounds, etc.

Contact Phone:

Contact Email:

Primavera Capital Group went public on 1/22/2021 on the NYSE

Listed Exchange:
NYSE

IPO Date:
1/22/2021

Ticker Symbol:
PV.U

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
1/2017 Koubei Private Equity Round 1.1B
10/2018 ByteDance Equity 3B
2/2022 Adden Energy Seed Round 5.2M
7/2021 OptoMedic Series D -
9/2021 Accession Therapeutics Limited Seed Round -
8/2022 Enflame Series C -
10/2019 Danke Apartment Series D 190M
6/2020 Xingsheng Youxuan Corporate Round -
3/2022 Hex Trust Series B 0
7/2017 Dashu Finance Series C 118M
4/2016 Ant Group Series B 0
4/2019 Onion Math Series D 44.7M
3/2016 Cainiao Logistics Series A 1.5B
5/2021 Analytical Biosciences Series A -
10/2021 Ruigu Series D 250M
6/2022 Project Twelve Seed Round 8M
2/2019 Danke Apartment Series C 500M
9/2012 Alibaba Group Private Equity Round 0
12/2021 Xbiome Series B 0
1/2021 Enflame Series C 278.8M
1/2021 4Paradigm Series D 0
5/2018 Souche Series F 578M
5/2022 Starna Therapeutics Series A 0
11/2022 Subtle Medical Series B 25M
11/2017 WorldStrides Private Equity Round -
5/2022 Trash Warrior Series A 0
12/2021 SyMap Medical Series E 100M
5/2021 Jenscare Biotech Venture Round -
8/2019 Ubox Corporate Round 225.5M
11/2020 Deepinfar Ocean Technology Series B 0
11/2019 LBX Pharmacy Post-IPO Secondary 557M
1/2020 Zap Surgical Systems Private Equity Round 0
12/2018 Lu.com Series C 0
8/2022 Pingxin Technology Series A -
10/2021 GoTo Group Private Equity Round 0
2/2022 Hong Kong Asia Heart Centre Series D 0
8/2018 Xpeng Motors Series B 584.5M
11/2017 Souche Series E 335M
1/2022 Starfield Food &a; Science Technology Series B 0
12/2018 Hello TransTech Series G 581.5M
6/2021 Trash Warrior Seed Round 1.5M
5/2022 Dimension Seed Round 8M
11/2019 Shijiazhuang Junlebao Dairy Funding Round 569.1M
11/2020 Xbiome Funding Round -
3/2022 Robotphoenix Series D 0
2/2021 Xingsheng Youxuan Series D 0
8/2021 Shukun Technology Series D 105.8M
1/2023 Blackpanda Series A 15M
10/2021 Love, Bonito Series C 0
3/2012 Xunlei Series E 50M
10/2021 Envision Group Private Equity Round 1B
9/2016 Yum! China Private Equity Round 460M
7/2018 Zuoyebang Series D 350M
11/2022 Accession Therapeutics Series A 0
5/2021 Beisen Series F 0
11/2018 Alibaba Bendi Shenghuo Fuwu Gongsi Funding Round 4B
12/2021 Avistone Pharmaceuticals Private Equity Round 0
7/2017 Moviebook Series C 73.8M
8/2022 Pingxin Technology Series A -
6/2022 Project Twelve Seed Round 0
5/2022 Trash Warrior Series A 0
5/2022 Starna Therapeutics Series A 0
3/2022 Hex Trust Series B 0
3/2022 Robotphoenix Series D 0
2/2022 Hong Kong Asia Heart Centre Series D 0
1/2022 Starfield Food &a; Science Technology Series B 0
12/2021 Xbiome Series B 0
12/2021 Avistone Pharmaceuticals Private Equity Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research